SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Xcyte Therapies, Inc. (XCYT)
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
16 4 0 XCYT
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16I know a little about CYCC. 96.5% because I find it interesting that they are rkenhott-7/2/2007
15>>Cyclacel Pharmaceuticals Initiates Phase I Study of CYC116 in Patients wtuck-6/29/2007
14You know the drill... open, no comparator arm, multiple baseline drugs, etc. Nokenhott-6/29/2007
13>>Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combintuck-6/28/2007
12I thought there was a Cyclacel thread, but couldn't find one. We should protuck-6/27/2007
11Xcyte Therapies, Inc. Announces Withdrawal Of Protocol for Phase II/III Clinicalmopgcw-2/3/2005
10a small buy establishing a small position...:LANGECKER PETER,Director,BUYS 2,000mopgcw-6/25/2004
9Chuckle. The only one missing from the offering is RBC...mopgcw-6/22/2004
8So they were all at H&Q, playing darts in the pub after the presentation, antuck-6/22/2004
7Xcyte Therapies Rated New `Market Perform' at Piper Jaffrey 2004-05-19 07:27mopgcw-6/22/2004
6cyte Therapies Rated New `Buy' at Wells Fargo :XCYT US 2004-04-26 08mopgcw-6/22/2004
5Xcyte Therapies Rated New `Market Outperform' at JMP :XCYT US 2004-05-04 0mopgcw-6/22/2004
4Hmmm, bit of an options overhang. 3.4 million shares controlled by options issutuck-6/22/2004
3Xcyte Therapies, Inc. Announces First Quarter 2004 Financial Results Dow Jonemopgcw-6/21/2004
2Xcyte Therapies, Inc., Presents Results of Clinical Trials in Chronic Lymphocytimopgcw-6/21/2004
1Less-than-spectacular initial public offering from Xcyte Biotech stocks retreamichael_f_murphy-3/17/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News